| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | H3K27me3 modified histone binding | 1.85e-06 | 5 | 115 | 3 | GO:0061628 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH11 MYO1C DNAH10 DHX57 ACSF2 ATP9A HSP90AA5P CHD5 DNAH17 ATP2A1 HSPA1A ATP2A2 HSPA1B TOP2A ALPL | 2.45e-06 | 614 | 115 | 15 | GO:0140657 |
| GeneOntologyMolecularFunction | actin filament binding | 5.14e-05 | 227 | 115 | 8 | GO:0051015 | |
| GeneOntologyMolecularFunction | transcription regulator inhibitor activity | 5.33e-05 | 36 | 115 | 4 | GO:0140416 | |
| GeneOntologyMolecularFunction | adenosylhomocysteinase activity | 9.83e-05 | 3 | 115 | 2 | GO:0004013 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-sulfur bonds | 9.83e-05 | 3 | 115 | 2 | GO:0046508 | |
| GeneOntologyMolecularFunction | denatured protein binding | 9.83e-05 | 3 | 115 | 2 | GO:0031249 | |
| GeneOntologyMolecularFunction | DNA binding, bending | 1.98e-04 | 20 | 115 | 3 | GO:0008301 | |
| GeneOntologyMolecularFunction | histone deacetylase binding | 2.09e-04 | 147 | 115 | 6 | GO:0042826 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DNAH10 DHX57 ATP9A HSP90AA5P CHD5 ATP2A1 HSPA1A ATP2A2 HSPA1B ALPL | 2.36e-04 | 441 | 115 | 10 | GO:0016887 |
| GeneOntologyMolecularFunction | death receptor agonist activity | 3.25e-04 | 5 | 115 | 2 | GO:0038177 | |
| GeneOntologyMolecularFunction | chromatin binding | VRK1 MEF2A JMJD1C MEF2C PBRM1 SBNO1 CHD5 SMARCC2 ZNF431 TAF1 TAF1L TOP1 TOP2A | 3.33e-04 | 739 | 115 | 13 | GO:0003682 |
| GeneOntologyMolecularFunction | supercoiled DNA binding | 4.86e-04 | 6 | 115 | 2 | GO:0097100 | |
| GeneOntologyMolecularFunction | ATP-dependent protein disaggregase activity | 4.86e-04 | 6 | 115 | 2 | GO:0140545 | |
| GeneOntologyMolecularFunction | C3HC4-type RING finger domain binding | 4.86e-04 | 6 | 115 | 2 | GO:0055131 | |
| GeneOntologyMolecularFunction | DNA topoisomerase activity | 9.00e-04 | 8 | 115 | 2 | GO:0003916 | |
| GeneOntologyMolecularFunction | RNA polymerase I general transcription initiation factor activity | 1.15e-03 | 9 | 115 | 2 | GO:0001181 | |
| GeneOntologyMolecularFunction | ATP-dependent protein folding chaperone | 1.57e-03 | 40 | 115 | 3 | GO:0140662 | |
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 1.75e-03 | 11 | 115 | 2 | GO:0005388 | |
| GeneOntologyMolecularFunction | actin binding | 1.82e-03 | 479 | 115 | 9 | GO:0003779 | |
| GeneOntologyMolecularFunction | structural constituent of muscle | 1.94e-03 | 43 | 115 | 3 | GO:0008307 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 1.97e-03 | 582 | 115 | 10 | GO:0140297 | |
| GeneOntologyMolecularFunction | heat shock protein binding | 2.54e-03 | 163 | 115 | 5 | GO:0031072 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 2.82e-03 | 167 | 115 | 5 | GO:0031490 | |
| GeneOntologyMolecularFunction | aminoacyl-tRNA editing activity | 2.86e-03 | 14 | 115 | 2 | GO:0002161 | |
| GeneOntologyMolecularFunction | macrolide binding | 2.86e-03 | 14 | 115 | 2 | GO:0005527 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 2.87e-03 | 417 | 115 | 8 | GO:0061629 | |
| GeneOntologyBiologicalProcess | myofibril assembly | 8.19e-06 | 86 | 114 | 6 | GO:0030239 | |
| GeneOntologyBiologicalProcess | striated muscle cell development | 9.99e-06 | 89 | 114 | 6 | GO:0055002 | |
| GeneOntologyBiologicalProcess | membraneless organelle assembly | KNTC1 FLII MYH11 NEBL NEB MEF2A MEF2C FARP2 TIMP2 CHEK2 HSPA1A HSPA1B | 1.28e-05 | 475 | 114 | 12 | GO:0140694 |
| GeneOntologyBiologicalProcess | DNA topological change | 1.92e-05 | 10 | 114 | 3 | GO:0006265 | |
| GeneOntologyBiologicalProcess | cellular anatomical entity morphogenesis | 2.59e-05 | 156 | 114 | 7 | GO:0032989 | |
| GeneOntologyBiologicalProcess | cellular component assembly involved in morphogenesis | 2.59e-05 | 156 | 114 | 7 | GO:0010927 | |
| GeneOntologyBiologicalProcess | reproductive senescence | 3.03e-05 | 2 | 114 | 2 | GO:1990636 | |
| GeneOntologyBiologicalProcess | negative regulation of inclusion body assembly | 3.49e-05 | 12 | 114 | 3 | GO:0090084 | |
| GeneOntologyBiologicalProcess | organelle assembly | KNTC1 FLII MYH11 TBC1D30 NEBL NEB AP3M1 MEF2A MEF2C FARP2 LRGUK TIMP2 DNAH17 CHEK2 HSPA1A ATP2A2 HSPA1B KNL1 | 5.11e-05 | 1138 | 114 | 18 | GO:0070925 |
| GeneOntologyBiologicalProcess | sister chromatid segregation | 8.47e-05 | 254 | 114 | 8 | GO:0000819 | |
| GeneOntologyBiologicalProcess | cardiac muscle thin filament assembly | 9.05e-05 | 3 | 114 | 2 | GO:0071691 | |
| GeneOntologyBiologicalProcess | positive regulation of endoplasmic reticulum calcium ion concentration | 9.05e-05 | 3 | 114 | 2 | GO:0032470 | |
| GeneOntologyBiologicalProcess | muscle cell development | 9.70e-05 | 259 | 114 | 8 | GO:0055001 | |
| GeneOntologyBiologicalProcess | chromosome organization | KNTC1 SHLD2 HMGB2 PBRM1 CHEK2 SMARCC2 HSPA1A HSPA1B TOP1 TOP2A KNL1 CPEB1 INO80E | 1.08e-04 | 686 | 114 | 13 | GO:0051276 |
| GeneOntologyBiologicalProcess | organelle localization | KNTC1 AHCYL1 MYO1C SYTL2 ATP9A AP3M1 MEF2A TRAPPC1 AP3M2 ATP2A1 ATP2A2 SLC4A5 KNL1 | 1.37e-04 | 703 | 114 | 13 | GO:0051640 |
| GeneOntologyBiologicalProcess | nuclear chromosome segregation | 1.62e-04 | 356 | 114 | 9 | GO:0098813 | |
| GeneOntologyBiologicalProcess | mitotic interphase | 1.80e-04 | 4 | 114 | 2 | GO:0051329 | |
| GeneOntologyBiologicalProcess | regulation of inclusion body assembly | 2.03e-04 | 21 | 114 | 3 | GO:0090083 | |
| GeneOntologyBiologicalProcess | cardiac myofibril assembly | 2.03e-04 | 21 | 114 | 3 | GO:0055003 | |
| GeneOntologyBiologicalProcess | chromosome segregation | KNTC1 PBRM1 CHEK2 SMARCC2 HSPA1A HSPA1B TOP1 TOP2A KNL1 CPEB1 | 2.59e-04 | 465 | 114 | 10 | GO:0007059 |
| GeneOntologyBiologicalProcess | interphase | 3.00e-04 | 5 | 114 | 2 | GO:0051325 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative metabolic process | TPST2 DPY19L2 NT5E TDG ACSF2 ADA2 NDUFB6 SULT1E1 LRGUK ADSS2 GUCY1B1 PGAP1 FUCA2 MMP12 DPY19L2P2 HSPA1A HSPA1B | 4.02e-04 | 1226 | 114 | 17 | GO:1901135 |
| GeneOntologyBiologicalProcess | cellular heat acclimation | 4.48e-04 | 6 | 114 | 2 | GO:0070370 | |
| GeneOntologyBiologicalProcess | somatic muscle development | 4.48e-04 | 6 | 114 | 2 | GO:0007525 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle phase | 4.48e-04 | 6 | 114 | 2 | GO:0098763 | |
| GeneOntologyBiologicalProcess | peptidyl-tryptophan modification | 4.48e-04 | 6 | 114 | 2 | GO:0018211 | |
| GeneOntologyBiologicalProcess | protein C-linked glycosylation via tryptophan | 4.48e-04 | 6 | 114 | 2 | GO:0018317 | |
| GeneOntologyBiologicalProcess | protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan | 4.48e-04 | 6 | 114 | 2 | GO:0018406 | |
| GeneOntologyBiologicalProcess | protein C-linked glycosylation | 4.48e-04 | 6 | 114 | 2 | GO:0018103 | |
| GeneOntologyBiologicalProcess | actin filament-based process | FLII MYH11 MYO1C NEBL NEB MEF2A MEF2C FARP2 FGD4 AIF1 AKAP11 ARPC5L ATP2A1 ATP2A2 | 5.07e-04 | 912 | 114 | 14 | GO:0030029 |
| GeneOntologyBiologicalProcess | purine ribonucleotide metabolic process | TPST2 NT5E ACSF2 NDUFB6 SULT1E1 LRGUK ADSS2 GUCY1B1 HSPA1A HSPA1B | 5.52e-04 | 512 | 114 | 10 | GO:0009150 |
| GeneOntologyBiologicalProcess | protein refolding | 5.99e-04 | 30 | 114 | 3 | GO:0042026 | |
| GeneOntologyBiologicalProcess | S-adenosylmethionine cycle | 6.24e-04 | 7 | 114 | 2 | GO:0033353 | |
| GeneOntologyBiologicalProcess | heat acclimation | 6.24e-04 | 7 | 114 | 2 | GO:0010286 | |
| GeneOntologyBiologicalProcess | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 6.24e-04 | 7 | 114 | 2 | GO:0070434 | |
| GeneOntologyBiologicalProcess | clathrin-coated vesicle cargo loading | 6.24e-04 | 7 | 114 | 2 | GO:0035652 | |
| GeneOntologyBiologicalProcess | clathrin-coated vesicle cargo loading, AP-3-mediated | 6.24e-04 | 7 | 114 | 2 | GO:0035654 | |
| GeneOntologyBiologicalProcess | calcium ion import into sarcoplasmic reticulum | 6.24e-04 | 7 | 114 | 2 | GO:1990036 | |
| GeneOntologyBiologicalProcess | ribonucleotide metabolic process | TPST2 NT5E ACSF2 NDUFB6 SULT1E1 LRGUK ADSS2 GUCY1B1 HSPA1A HSPA1B | 7.52e-04 | 533 | 114 | 10 | GO:0009259 |
| GeneOntologyBiologicalProcess | inclusion body assembly | 7.95e-04 | 33 | 114 | 3 | GO:0070841 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | VRK1 MYO1C HMGB2 TDG JMJD1C PBRM1 CHD5 SMARCC2 TAF1 TAF1L TOP1 INO80E | 8.20e-04 | 741 | 114 | 12 | GO:0006338 |
| GeneOntologyBiologicalProcess | DNA damage response | SHLD2 VRK1 EXO5 RADX HMGB2 TDG PBRM1 CHEK2 SMARCC2 TAF1 HSPA1A HSPA1B TOP2A INO80E | 8.29e-04 | 959 | 114 | 14 | GO:0006974 |
| GeneOntologyBiologicalProcess | positive regulation of endothelial cell development | 8.30e-04 | 8 | 114 | 2 | GO:1901552 | |
| GeneOntologyBiologicalProcess | positive regulation of microtubule nucleation | 8.30e-04 | 8 | 114 | 2 | GO:0090063 | |
| GeneOntologyBiologicalProcess | positive regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway | 8.30e-04 | 8 | 114 | 2 | GO:0070426 | |
| GeneOntologyBiologicalProcess | positive regulation of establishment of endothelial barrier | 8.30e-04 | 8 | 114 | 2 | GO:1903142 | |
| GeneOntologyBiologicalProcess | ribose phosphate metabolic process | TPST2 NT5E ACSF2 NDUFB6 SULT1E1 LRGUK ADSS2 GUCY1B1 HSPA1A HSPA1B | 8.30e-04 | 540 | 114 | 10 | GO:0019693 |
| GeneOntologyBiologicalProcess | cardiac cell development | 8.36e-04 | 132 | 114 | 5 | GO:0055006 | |
| GeneOntologyBiologicalProcess | DNA repair | SHLD2 EXO5 RADX HMGB2 TDG PBRM1 CHEK2 SMARCC2 HSPA1A HSPA1B INO80E | 9.30e-04 | 648 | 114 | 11 | GO:0006281 |
| GeneOntologyBiologicalProcess | purine-containing compound metabolic process | TPST2 NT5E ACSF2 ADA2 NDUFB6 SULT1E1 LRGUK ADSS2 GUCY1B1 HSPA1A HSPA1B | 9.78e-04 | 652 | 114 | 11 | GO:0072521 |
| Domain | HJURP_C | 8.14e-07 | 4 | 111 | 3 | IPR022102 | |
| Domain | MADS_MEF2-like | 8.14e-07 | 4 | 111 | 3 | IPR033896 | |
| Domain | HJURP_C | 8.14e-07 | 4 | 111 | 3 | PF12347 | |
| Domain | MADS_BOX_1 | 4.03e-06 | 6 | 111 | 3 | PS00350 | |
| Domain | MADS | 4.03e-06 | 6 | 111 | 3 | SM00432 | |
| Domain | SRF-TF | 4.03e-06 | 6 | 111 | 3 | PF00319 | |
| Domain | MADS_BOX_2 | 4.03e-06 | 6 | 111 | 3 | PS50066 | |
| Domain | TF_MADSbox | 7.03e-06 | 7 | 111 | 3 | IPR002100 | |
| Domain | TFIID_sub1_DUF3591 | 3.50e-05 | 2 | 111 | 2 | IPR022591 | |
| Domain | TBP-binding | 3.50e-05 | 2 | 111 | 2 | PF09247 | |
| Domain | DUF3591 | 3.50e-05 | 2 | 111 | 2 | PF12157 | |
| Domain | TAF_II_230-bd | 3.50e-05 | 2 | 111 | 2 | IPR009067 | |
| Domain | - | 3.50e-05 | 2 | 111 | 2 | 1.10.1100.10 | |
| Domain | TAF1_animal | 3.50e-05 | 2 | 111 | 2 | IPR011177 | |
| Domain | AdoHcyase_NAD | 1.05e-04 | 3 | 111 | 2 | SM00997 | |
| Domain | AdoHcyase | 1.05e-04 | 3 | 111 | 2 | SM00996 | |
| Domain | AdoHcyase_NAD | 1.05e-04 | 3 | 111 | 2 | PF00670 | |
| Domain | ADOHCYASE_1 | 1.05e-04 | 3 | 111 | 2 | PS00738 | |
| Domain | ADOHCYASE_2 | 1.05e-04 | 3 | 111 | 2 | PS00739 | |
| Domain | AdoHcyase | 1.05e-04 | 3 | 111 | 2 | PF05221 | |
| Domain | Ado_hCys_hydrolase_NAD-bd | 1.05e-04 | 3 | 111 | 2 | IPR015878 | |
| Domain | S-Ado-L-homoCys_hydrolase_CS | 1.05e-04 | 3 | 111 | 2 | IPR020082 | |
| Domain | P-type_ATPase_IIA | 1.05e-04 | 3 | 111 | 2 | IPR005782 | |
| Domain | Adenosylhomocysteinase | 1.05e-04 | 3 | 111 | 2 | IPR000043 | |
| Domain | Nebulin | 2.08e-04 | 4 | 111 | 2 | PF00880 | |
| Domain | NEBULIN | 2.08e-04 | 4 | 111 | 2 | PS51216 | |
| Domain | NEBU | 2.08e-04 | 4 | 111 | 2 | SM00227 | |
| Domain | Nebulin | 2.08e-04 | 4 | 111 | 2 | IPR013998 | |
| Domain | Nebulin_repeat | 2.08e-04 | 4 | 111 | 2 | IPR000900 | |
| Domain | Bromodomain_CS | 4.81e-04 | 26 | 111 | 3 | IPR018359 | |
| Domain | Clathrin_mu_CS | 5.17e-04 | 6 | 111 | 2 | IPR018240 | |
| Domain | CLAT_ADAPTOR_M_1 | 5.17e-04 | 6 | 111 | 2 | PS00990 | |
| Domain | CLAT_ADAPTOR_M_2 | 5.17e-04 | 6 | 111 | 2 | PS00991 | |
| Domain | Val/Leu/Ile-tRNA-synth_edit | 5.17e-04 | 6 | 111 | 2 | IPR009008 | |
| Domain | Anticodon_1 | 5.17e-04 | 6 | 111 | 2 | PF08264 | |
| Domain | M/V/L/I-tRNA-synth_anticd-bd | 5.17e-04 | 6 | 111 | 2 | IPR013155 | |
| Domain | - | 5.17e-04 | 6 | 111 | 2 | 3.90.740.10 | |
| Domain | Longin-like_dom | 6.01e-04 | 28 | 111 | 3 | IPR011012 | |
| Domain | aa-tRNA-synth_Ia | 7.21e-04 | 7 | 111 | 2 | IPR002300 | |
| Domain | tRNA-synt_1 | 7.21e-04 | 7 | 111 | 2 | PF00133 | |
| Domain | - | 8.94e-04 | 32 | 111 | 3 | 3.40.1110.10 | |
| Domain | - | 8.94e-04 | 32 | 111 | 3 | 2.70.150.10 | |
| Domain | ATPase_P-typ_cyto_domN | 1.16e-03 | 35 | 111 | 3 | IPR023299 | |
| Domain | ATPase_P-typ_P_site | 1.26e-03 | 36 | 111 | 3 | IPR018303 | |
| Domain | P_typ_ATPase | 1.26e-03 | 36 | 111 | 3 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 1.26e-03 | 36 | 111 | 3 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 1.37e-03 | 37 | 111 | 3 | IPR008250 | |
| Domain | E1-E2_ATPase | 1.37e-03 | 37 | 111 | 3 | PF00122 | |
| Domain | BROMODOMAIN_1 | 1.37e-03 | 37 | 111 | 3 | PS00633 | |
| Domain | Bromodomain | 1.48e-03 | 38 | 111 | 3 | PF00439 | |
| Domain | Hydrolase_3 | 1.53e-03 | 10 | 111 | 2 | PF08282 | |
| Domain | Clathrin_mu | 1.53e-03 | 10 | 111 | 2 | IPR001392 | |
| Domain | BROMODOMAIN_2 | 1.85e-03 | 41 | 111 | 3 | PS50014 | |
| Domain | Adap_comp_sub | 1.86e-03 | 11 | 111 | 2 | PF00928 | |
| Domain | - | 1.86e-03 | 11 | 111 | 2 | 1.10.730.10 | |
| Domain | Bromodomain | 1.98e-03 | 42 | 111 | 3 | IPR001487 | |
| Domain | BROMO | 1.98e-03 | 42 | 111 | 3 | SM00297 | |
| Domain | - | 1.98e-03 | 42 | 111 | 3 | 1.20.920.10 | |
| Domain | Rossmann-like_a/b/a_fold | 2.12e-03 | 43 | 111 | 3 | IPR014729 | |
| Domain | - | 2.12e-03 | 43 | 111 | 3 | 3.40.50.620 | |
| Domain | Clathrin_sm-chain_CS | 2.22e-03 | 12 | 111 | 2 | IPR000804 | |
| Domain | MHD | 2.62e-03 | 13 | 111 | 2 | PS51072 | |
| Domain | MHD | 2.62e-03 | 13 | 111 | 2 | IPR028565 | |
| Domain | tRNAsynth_Ia_anticodon-bd | 3.49e-03 | 15 | 111 | 2 | IPR009080 | |
| Domain | PH_dom-like | 3.92e-03 | 426 | 111 | 8 | IPR011993 | |
| Domain | AP_mu_sigma_su | 3.98e-03 | 16 | 111 | 2 | IPR022775 | |
| Domain | Clat_adaptor_s | 3.98e-03 | 16 | 111 | 2 | PF01217 | |
| Domain | ATPase_P-typ_TM_dom | 3.98e-03 | 16 | 111 | 2 | IPR023298 | |
| Domain | - | 3.98e-03 | 16 | 111 | 2 | 1.20.1110.10 | |
| Domain | HSP70 | 3.98e-03 | 16 | 111 | 2 | PF00012 | |
| Domain | HMG_BOX_2 | 4.07e-03 | 54 | 111 | 3 | PS50118 | |
| Domain | - | 4.28e-03 | 55 | 111 | 3 | 1.10.30.10 | |
| Domain | HSP70_2 | 4.49e-03 | 17 | 111 | 2 | PS00329 | |
| Domain | ATPase_P-typ_cation-transptr_C | 4.49e-03 | 17 | 111 | 2 | IPR006068 | |
| Domain | Cation_ATPase_C | 4.49e-03 | 17 | 111 | 2 | PF00689 | |
| Domain | HSP70_1 | 4.49e-03 | 17 | 111 | 2 | PS00297 | |
| Domain | HSP70_3 | 4.49e-03 | 17 | 111 | 2 | PS01036 | |
| Domain | aa-tRNA-synth_I_CS | 5.03e-03 | 18 | 111 | 2 | IPR001412 | |
| Domain | Cation_ATPase_N | 5.03e-03 | 18 | 111 | 2 | PF00690 | |
| Domain | Cation_ATPase_N | 5.03e-03 | 18 | 111 | 2 | SM00831 | |
| Domain | Hsp_70_fam | 5.03e-03 | 18 | 111 | 2 | IPR013126 | |
| Domain | ATPase_P-typ_cation-transptr_N | 5.60e-03 | 19 | 111 | 2 | IPR004014 | |
| Domain | AA_TRNA_LIGASE_I | 5.60e-03 | 19 | 111 | 2 | PS00178 | |
| Pubmed | AHCYL1 MYO1C DNAH10 RADX IARS1 LARS1 HMGB2 MEF2A JMJD1C MEF2C MEF2D PBRM1 CHD5 ARID5B SMARCC2 TAF1 ATP2A2 TAF1L TOP1 MRPL1 CPEB1 INO80E | 2.20e-09 | 1429 | 117 | 22 | 35140242 | |
| Pubmed | RPL21 KNTC1 AHCYL1 MYH11 ADAP1 MYO1C DHX57 HMGB2 AHCYL2 NEB RBM22 SBNO1 DNAJA4 CHD5 CYCS SMARCC2 ARPC5L METTL25 ATP2A1 ATP2A2 TOP1 TOP2A | 2.60e-09 | 1442 | 117 | 22 | 35575683 | |
| Pubmed | An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133. | 3.71e-08 | 3 | 117 | 3 | 18093911 | |
| Pubmed | In vivo analysis of MEF2 transcription factors in synapse regulation and neuronal survival. | 3.71e-08 | 3 | 117 | 3 | 22496871 | |
| Pubmed | 3.71e-08 | 3 | 117 | 3 | 27989458 | ||
| Pubmed | 3.71e-08 | 3 | 117 | 3 | 15834131 | ||
| Pubmed | 3.71e-08 | 3 | 117 | 3 | 26286136 | ||
| Pubmed | 3.71e-08 | 3 | 117 | 3 | 33315889 | ||
| Pubmed | FLII DCHS2 AHCYL1 ADAM9 MCF2L2 LARS1 TRAPPC1 TXNDC11 RBM22 SBNO1 GUCY1B1 ARID5B TAF1 HSPA1A ATP2A2 HSPA1B UTRN TOP1 ALPL | 5.95e-08 | 1285 | 117 | 19 | 35914814 | |
| Pubmed | RPL21 FLII AHCYL1 MYH11 MYO1C IARS1 LARS1 DHX57 ATP9A AP3M1 TRAPPC1 FGD4 CYCS SMARCC2 ARPC5L HSPA1A ATP2A2 HSPA1B UTRN TOP1 | 6.39e-08 | 1431 | 117 | 20 | 37142655 | |
| Pubmed | COL12A1 MYO1C IARS1 ADAM9 LARS1 HMGB2 NDUFB6 MELK AP3M1 NSDHL DNAJA4 PREP CHEK2 SMARCC2 PLCB4 ATP2A2 HSPA1B TOP1 ATPAF1 | 6.87e-08 | 1297 | 117 | 19 | 33545068 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | VRK1 HMGB2 CWC25 JMJD1C MEF2D CYCS SMARCC2 TAF1 ATP2A1 HSPA1A ATP2A2 TAF1L TOP1 MRPL1 TOP2A KNL1 | 1.37e-07 | 954 | 117 | 16 | 36373674 |
| Pubmed | 1.48e-07 | 4 | 117 | 3 | 22764880 | ||
| Pubmed | 1.48e-07 | 4 | 117 | 3 | 8575763 | ||
| Pubmed | 1.48e-07 | 4 | 117 | 3 | 10207130 | ||
| Pubmed | 1.48e-07 | 4 | 117 | 3 | 21531906 | ||
| Pubmed | Requirement of MEF2A, C, and D for skeletal muscle regeneration. | 1.48e-07 | 4 | 117 | 3 | 24591619 | |
| Pubmed | Expression of mef2 genes in the mouse central nervous system suggests a role in neuronal maturation. | 1.48e-07 | 4 | 117 | 3 | 7643214 | |
| Pubmed | 1.48e-07 | 4 | 117 | 3 | 25416778 | ||
| Pubmed | 1.48e-07 | 4 | 117 | 3 | 31420455 | ||
| Pubmed | 1.48e-07 | 4 | 117 | 3 | 8817457 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | RPL21 KNTC1 MYH11 MYO1C IARS1 LARS1 HMGB2 HSP90AA5P PBRM1 SMARCC2 ARPC5L HSPA1A HSPA1B UTRN TOP1 | 1.75e-07 | 847 | 117 | 15 | 35235311 |
| Pubmed | RPL21 FLII AHCYL1 MYO1C NEBL NT5E IARS1 LARS1 HMGB2 MEF2D RBM22 ADSS2 SMARCC2 HSPA1A ATP2A2 TOP1 FKBP5 TOP2A | 1.97e-07 | 1247 | 117 | 18 | 27684187 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RPL21 KNTC1 FLII VRK1 MYO1C DNAH10 IARS1 LARS1 NSDHL RBM22 PBRM1 ADSS2 SBNO1 CYCS MED23 HSPA1A ATP2A2 TOP1 TOP2A | 2.92e-07 | 1425 | 117 | 19 | 30948266 |
| Pubmed | Control of the SOST bone enhancer by PTH using MEF2 transcription factors. | 3.69e-07 | 5 | 117 | 3 | 17696759 | |
| Pubmed | The MEF2B homologue differentially expressed in mouse embryonal carcinoma cells. | 3.69e-07 | 5 | 117 | 3 | 7646512 | |
| Pubmed | Interaction of myocyte enhancer factor 2 (MEF2) with a mitogen-activated protein kinase, ERK5/BMK1. | 3.69e-07 | 5 | 117 | 3 | 9753748 | |
| Pubmed | 3.69e-07 | 5 | 117 | 3 | 8993831 | ||
| Pubmed | Regulation of the MEF2 family of transcription factors by p38. | 3.69e-07 | 5 | 117 | 3 | 9858528 | |
| Pubmed | Galpha13 regulates MEF2-dependent gene transcription in endothelial cells: role in angiogenesis. | 3.69e-07 | 5 | 117 | 3 | 19093215 | |
| Pubmed | Calcineurin initiates skeletal muscle differentiation by activating MEF2 and MyoD. | 3.69e-07 | 5 | 117 | 3 | 12694204 | |
| Pubmed | 3.69e-07 | 5 | 117 | 3 | 10458488 | ||
| Pubmed | 3.69e-07 | 5 | 117 | 3 | 20833138 | ||
| Pubmed | 3.69e-07 | 5 | 117 | 3 | 23511190 | ||
| Pubmed | Regulatory role of MEF2D in serum induction of the c-jun promoter. | 3.69e-07 | 5 | 117 | 3 | 7760790 | |
| Pubmed | 3.69e-07 | 5 | 117 | 3 | 8900141 | ||
| Pubmed | MEF2 transcription factors are key regulators of sprouting angiogenesis. | 3.69e-07 | 5 | 117 | 3 | 27898394 | |
| Pubmed | 7.37e-07 | 6 | 117 | 3 | 20399744 | ||
| Pubmed | 7.37e-07 | 6 | 117 | 3 | 10737771 | ||
| Pubmed | The expression of MEF2 genes is implicated in CNS neuronal differentiation. | 7.37e-07 | 6 | 117 | 3 | 9013788 | |
| Pubmed | KNTC1 IARS1 LARS1 HMGB2 MEF2A JMJD1C MEF2D RBM22 SMARCC2 MED23 ATP2A2 HSPA1B TOP1 FKBP5 TOP2A KNL1 | 9.41e-07 | 1103 | 117 | 16 | 34189442 | |
| Pubmed | Targeting the interaction of AIMP2-DX2 with HSP70 suppresses cancer development. | 1.10e-06 | 54 | 117 | 5 | 31792442 | |
| Pubmed | KNTC1 NEBL RADX SYTL2 CWC25 MELK JMJD1C NSDHL FARP2 GUCY1B1 PRR14L FKBP5 KNL1 | 1.21e-06 | 733 | 117 | 13 | 34672954 | |
| Pubmed | Mef2 gene expression marks the cardiac and skeletal muscle lineages during mouse embryogenesis. | 1.29e-06 | 7 | 117 | 3 | 8026334 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | RPL21 FLII MYH11 MYO1C IARS1 SMARCC2 ARPC5L ATP2A1 HSPA1A ATP2A2 HSPA1B TOP2A | 2.01e-06 | 647 | 117 | 12 | 26618866 |
| Pubmed | 2.05e-06 | 8 | 117 | 3 | 16043483 | ||
| Pubmed | Hsp72 preserves muscle function and slows progression of severe muscular dystrophy. | 2.05e-06 | 8 | 117 | 3 | 22495301 | |
| Pubmed | Histone deacetylase degradation and MEF2 activation promote the formation of slow-twitch myofibers. | 2.05e-06 | 8 | 117 | 3 | 17786239 | |
| Pubmed | MEF2B Instructs Germinal Center Development and Acts as an Oncogene in B Cell Lymphomagenesis. | 2.05e-06 | 8 | 117 | 3 | 30205047 | |
| Pubmed | RPL21 MYO1C IARS1 LARS1 HMGB2 HSP90AA5P ARPC5L HSPA1A UTRN TOP1 TOP2A | 2.17e-06 | 538 | 117 | 11 | 28524877 | |
| Pubmed | RNF38 suppress growth and metastasis via ubiquitination of ACTN4 in nasopharyngeal carcinoma. | 2.19e-06 | 62 | 117 | 5 | 35568845 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RPL21 FLII AHCYL1 MYO1C DSC3 IARS1 LARS1 DHX57 MELK RBM22 ADSS2 SMARCC2 PRR14L ATP2A2 UTRN TOP1 TOP2A | 2.94e-06 | 1353 | 117 | 17 | 29467282 |
| Pubmed | 3.07e-06 | 9 | 117 | 3 | 9738004 | ||
| Pubmed | A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis. | 3.09e-06 | 118 | 117 | 6 | 27377895 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | MYH11 MYO1C IARS1 LARS1 HMGB2 NSDHL ADSS2 SMARCC2 ATP2A1 ATP2A2 HSPA1B UTRN TOP1 | 3.46e-06 | 807 | 117 | 13 | 30575818 |
| Pubmed | 3.70e-06 | 268 | 117 | 8 | 33640491 | ||
| Pubmed | 4.38e-06 | 10 | 117 | 3 | 30276662 | ||
| Pubmed | Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. | 6.00e-06 | 11 | 117 | 3 | 9162005 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | RPL21 VRK1 IARS1 LARS1 MEF2A JMJD1C MEF2C MEF2D NSDHL RBM22 CHEK2 SMARCC2 TOP2A | 6.61e-06 | 857 | 117 | 13 | 25609649 |
| Pubmed | RPL21 AHCYL1 MYH11 RADX IARS1 LARS1 DHX57 HMGB2 AHCYL2 HSP90AA5P AP3M1 CHD5 SMARCC2 TOP1 FKBP5 | 7.87e-06 | 1153 | 117 | 15 | 29845934 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 7.89e-06 | 394 | 117 | 9 | 27248496 | |
| Pubmed | 7.98e-06 | 12 | 117 | 3 | 28641113 | ||
| Pubmed | Skeletal muscle specification by myogenin and Mef2D via the SWI/SNF ATPase Brg1. | 7.98e-06 | 12 | 117 | 3 | 16424906 | |
| Pubmed | 1.04e-05 | 13 | 117 | 3 | 21447557 | ||
| Pubmed | 1.04e-05 | 13 | 117 | 3 | 17158748 | ||
| Pubmed | Exercise induces hepatosplanchnic release of heat shock protein 72 in humans. | 1.12e-05 | 2 | 117 | 2 | 12411538 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 2868009 | ||
| Pubmed | Up-regulation of inducible heat shock protein-70 expression in multiple sclerosis patients. | 1.12e-05 | 2 | 117 | 2 | 24328534 | |
| Pubmed | Myocyte enhancer factors 2A and 2C induce dilated cardiomyopathy in transgenic mice. | 1.12e-05 | 2 | 117 | 2 | 16469744 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 3786141 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 25336633 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 12556521 | ||
| Pubmed | Characterization of the binding between a 70-kDa heat shock protein, HspA1A, and phosphoinositides. | 1.12e-05 | 2 | 117 | 2 | 26923070 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 23184149 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 16482515 | ||
| Pubmed | Effect of hyaluronan oligosaccharides on the expression of heat shock protein 72. | 1.12e-05 | 2 | 117 | 2 | 11864979 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 24130054 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 15719414 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 26976620 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 19644701 | ||
| Pubmed | Targeting membrane heat-shock protein 70 (Hsp70) on tumors by cmHsp70.1 antibody. | 1.12e-05 | 2 | 117 | 2 | 21187371 | |
| Pubmed | Radiation therapy induces circulating serum Hsp72 in patients with prostate cancer. | 1.12e-05 | 2 | 117 | 2 | 20430459 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 20235222 | ||
| Pubmed | Genetic determinants of HSP70 gene expression following heat shock. | 1.12e-05 | 2 | 117 | 2 | 20876613 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 20223214 | ||
| Pubmed | Sarco(endo)plasmic reticulum Ca2+ ATPases (SERCA1 and -2) in human extraocular muscles. | 1.12e-05 | 2 | 117 | 2 | 14638697 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 20093776 | ||
| Pubmed | Bacterial infection elicits heat shock protein 72 release from pleural mesothelial cells. | 1.12e-05 | 2 | 117 | 2 | 23704948 | |
| Pubmed | Structure and expression of the human gene encoding major heat shock protein HSP70. | 1.12e-05 | 2 | 117 | 2 | 2858050 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 17513788 | ||
| Pubmed | IL-6 activates HSP72 gene expression in human skeletal muscle. | 1.12e-05 | 2 | 117 | 2 | 12207910 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 28837204 | ||
| Pubmed | Loss of myocyte enhancer factor 2 expression in osteoclasts leads to opposing skeletal phenotypes. | 1.12e-05 | 2 | 117 | 2 | 32512162 | |
| Pubmed | Regulation of myocyte enhancer factor-2 transcription factors by neurotoxins. | 1.12e-05 | 2 | 117 | 2 | 21741404 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 29572464 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 15988927 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 38804708 | ||
| Pubmed | Molecular Pathway to Protection From Age-Dependent Photoreceptor Degeneration in Mef2 Deficiency. | 1.12e-05 | 2 | 117 | 2 | 28738418 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 26448330 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 12714332 | ||
| Interaction | JUN interactions | AHCYL1 VRK1 IARS1 TDG AHCYL2 MEF2A MEF2D SMARCC2 TAF1 TOP1 TOP2A CPEB1 | 1.45e-05 | 470 | 114 | 12 | int:JUN |
| Interaction | MAPK7 interactions | 1.71e-05 | 143 | 114 | 7 | int:MAPK7 | |
| Interaction | SH3BGRL interactions | 2.53e-05 | 152 | 114 | 7 | int:SH3BGRL | |
| Interaction | MEF2B interactions | 2.81e-05 | 11 | 114 | 3 | int:MEF2B | |
| Interaction | AR interactions | FLII AHCYL1 MYO1C IARS1 HMGB2 TDG MEF2A JMJD1C MEF2D PBRM1 ARID5B SMARCC2 TAF1 MED23 HSPA1A FKBP5 KNL1 | 4.18e-05 | 992 | 114 | 17 | int:AR |
| Interaction | SOX2 interactions | FLII AHCYL1 MYO1C DSC3 NT5E LARS1 DHX57 CWC25 MEF2A JMJD1C MEF2C MEF2D PBRM1 PREP ARID5B SMARCC2 AKAP11 ARPC5L TOP1 MRPL1 KNL1 | 4.31e-05 | 1422 | 114 | 21 | int:SOX2 |
| Cytoband | 6q24 | 1.79e-04 | 8 | 117 | 2 | 6q24 | |
| GeneFamily | Myocyte enhancer factor 2 proteins|MADS box family | 3.59e-07 | 4 | 82 | 3 | 649 | |
| GeneFamily | Myocyte enhancer factor 2 proteins|MADS box family | 8.93e-07 | 5 | 82 | 3 | 1086 | |
| GeneFamily | Topoisomerases | 3.01e-04 | 6 | 82 | 2 | 1050 | |
| GeneFamily | ATPases Ca2+ transporting | 7.17e-04 | 9 | 82 | 2 | 1209 | |
| GeneFamily | Dyneins, axonemal | 2.64e-03 | 17 | 82 | 2 | 536 | |
| GeneFamily | Heat shock 70kDa proteins | 2.64e-03 | 17 | 82 | 2 | 583 | |
| GeneFamily | Aminoacyl tRNA synthetases, Class I | 3.30e-03 | 19 | 82 | 2 | 131 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.35e-03 | 66 | 82 | 3 | 722 | |
| Coexpression | GSE21380_NON_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_DN | 2.76e-07 | 200 | 116 | 9 | M7505 | |
| Coexpression | GSE8685_IL2_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP | 1.11e-06 | 174 | 116 | 8 | M333 | |
| Coexpression | GSE7852_TREG_VS_TCONV_LN_UP | 3.14e-06 | 200 | 116 | 8 | M5727 | |
| Coexpression | GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_AND_IL10_STIM_MACROPHAGE_DN | 9.04e-06 | 165 | 116 | 7 | M8121 | |
| Coexpression | GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_UP | 1.38e-05 | 176 | 116 | 7 | M2981 | |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 1.43e-05 | 177 | 116 | 7 | M39245 | |
| Coexpression | GSE37301_HEMATOPOIETIC_STEM_CELL_VS_RAG2_KO_NK_CELL_DN | 1.77e-05 | 183 | 116 | 7 | M8886 | |
| Coexpression | HALLMARK_MYOGENESIS | 3.13e-05 | 200 | 116 | 7 | M5909 | |
| Coexpression | GSE3982_MAC_VS_BCELL_UP | 3.13e-05 | 200 | 116 | 7 | M5494 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | COL12A1 MYO1C NEBL NT5E ADAM9 MEF2C FGD4 ARID5B PPP1R2P1 MED23 HSPA1A HSPA1B CDH5 NSMAF | 3.90e-05 | 888 | 116 | 14 | MM1018 |
| Coexpression | FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP | 4.54e-05 | 16 | 116 | 3 | MM559 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | KNTC1 IARS1 LARS1 HMGB2 TDG MELK AP3M1 FARP2 GUCY1B1 PGAP1 CYCS CHEK2 AP3M2 ZNF431 MMP12 FKBP5 TOP2A KNL1 | 4.60e-05 | 1407 | 116 | 18 | M14427 |
| Coexpression | EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION | 6.10e-05 | 48 | 116 | 4 | M16123 | |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP | 6.57e-05 | 305 | 116 | 8 | M19875 | |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 6.74e-05 | 155 | 116 | 6 | M39246 | |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | TBC1D30 NT5E LARS1 JMJD1C ADSS2 PGAP1 ARID5B UTRN NSMAF KNL1 | 7.57e-05 | 498 | 116 | 10 | M1741 |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | TBC1D30 NT5E LARS1 JMJD1C ADSS2 PGAP1 ARID5B UTRN NSMAF KNL1 | 8.78e-05 | 507 | 116 | 10 | MM1030 |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP | 9.78e-05 | 323 | 116 | 8 | M2156 | |
| Coexpression | KIM_WT1_TARGETS_8HR_UP | 1.02e-04 | 167 | 116 | 6 | M8857 | |
| Coexpression | MACLACHLAN_BRCA1_TARGETS_UP | 1.06e-04 | 21 | 116 | 3 | M17772 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | COL12A1 MYO1C NEBL NT5E ADAM9 MEF2C FGD4 ARID5B MED23 HSPA1A HSPA1B CDH5 NSMAF | 1.06e-04 | 854 | 116 | 13 | M1533 |
| Coexpression | GSE32901_NAIVE_VS_TH17_NEG_CD4_TCELL_UP | 1.20e-04 | 172 | 116 | 6 | M8932 | |
| Coexpression | GSE6259_33D1_POS_DC_VS_CD4_TCELL_UP | 1.73e-04 | 184 | 116 | 6 | M6756 | |
| Coexpression | GSE32255_UNSTIM_VS_4H_LPS_STIM_DC_UP | 1.83e-04 | 186 | 116 | 6 | M8914 | |
| Coexpression | TURJANSKI_MAPK11_TARGETS | 1.92e-04 | 5 | 116 | 2 | M2492 | |
| Coexpression | GRUETZMANN_PANCREATIC_CANCER_UP | 2.01e-04 | 359 | 116 | 8 | M15193 | |
| Coexpression | AIZARANI_LIVER_C18_NK_NKT_CELLS_5 | 2.06e-04 | 121 | 116 | 5 | M39120 | |
| Coexpression | DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN | 2.12e-04 | 66 | 116 | 4 | M4001 | |
| Coexpression | GSE37416_CTRL_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP | 2.24e-04 | 193 | 116 | 6 | M5339 | |
| Coexpression | REICHERT_MITOSIS_LIN9_TARGETS | 2.29e-04 | 27 | 116 | 3 | M2483 | |
| Coexpression | REICHERT_MITOSIS_LIN9_TARGETS | 2.55e-04 | 28 | 116 | 3 | MM1323 | |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_DN | 2.57e-04 | 198 | 116 | 6 | M8274 | |
| Coexpression | GSE39556_CD8A_DC_VS_NK_CELL_MOUSE_3H_POST_POLYIC_INJ_UP | 2.64e-04 | 199 | 116 | 6 | M9419 | |
| Coexpression | GSE25087_TREG_VS_TCONV_ADULT_UP | 2.64e-04 | 199 | 116 | 6 | M4650 | |
| Coexpression | ZHENG_FOXP3_TARGETS_IN_THYMUS_UP | 2.64e-04 | 199 | 116 | 6 | M1746 | |
| Coexpression | GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_48H_UP | 2.64e-04 | 199 | 116 | 6 | M6040 | |
| Coexpression | GSE42021_TREG_PLN_VS_CD24INT_TREG_THYMUS_UP | 2.71e-04 | 200 | 116 | 6 | M9614 | |
| Coexpression | GSE17721_LPS_VS_PAM3CSK4_24H_BMDC_DN | 2.71e-04 | 200 | 116 | 6 | M3931 | |
| Coexpression | GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_UP | 2.71e-04 | 200 | 116 | 6 | M5041 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP | 2.71e-04 | 200 | 116 | 6 | M6609 | |
| Coexpression | HALLMARK_COMPLEMENT | 2.71e-04 | 200 | 116 | 6 | M5921 | |
| Coexpression | GSE5142_CTRL_VS_HTERT_TRANSDUCED_CD8_TCELL_EARLY_PASSAGE_CLONE_UP | 2.71e-04 | 200 | 116 | 6 | M6549 | |
| Coexpression | GSE17721_0.5H_VS_4H_PAM3CSK4_BMDC_UP | 2.71e-04 | 200 | 116 | 6 | M4105 | |
| Coexpression | ZHENG_FOXP3_TARGETS_IN_THYMUS_UP | 2.71e-04 | 200 | 116 | 6 | MM1033 | |
| Coexpression | GSE7460_TCONV_VS_TREG_LN_DN | 2.71e-04 | 200 | 116 | 6 | M5674 | |
| Coexpression | CADWELL_ATG16L1_TARGETS_DN | 2.82e-04 | 71 | 116 | 4 | M12482 | |
| Coexpression | CADWELL_ATG16L1_TARGETS_DN | 3.30e-04 | 74 | 116 | 4 | MM768 | |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 3.65e-04 | 137 | 116 | 5 | M39241 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5 | 3.81e-04 | 32 | 116 | 3 | MM1278 | |
| CoexpressionAtlas | B cells, proB.FrBC.BM, CD19+ IgM- CD43+ AA4.1+ CD45R+, Bone marrow, avg-2 | KNTC1 MYO1C HMGB2 LCN2 MELK MEF2C PREP ARPC5L TOP2A ALPL KNL1 | 9.04e-06 | 401 | 112 | 11 | GSM399450_500 |
| CoexpressionAtlas | B cells, B.GC.Sp, CD19+ IgM+ IgD- GL7+ PNA+, Spleen, avg-3 | 3.35e-05 | 380 | 112 | 10 | GSM538207_500 | |
| CoexpressionAtlas | e9.5_MandibArch_top-relative-expression-ranked_500_2 | 4.98e-05 | 14 | 112 | 3 | Facebase_ST1_e9.5_MandibArch_500_2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.51e-05 | 184 | 112 | 7 | gudmap_developingLowerUrinaryTract_P1_ureter_1000_k2 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_1000 | 6.87e-05 | 333 | 112 | 9 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k1_1000 | |
| CoexpressionAtlas | B cells, proB.CLP.BM, AA4.1+ CD117+ IL7R+ CD45R- CD24- CD19- IgM-, Bone marrow, avg-1 | 7.69e-05 | 338 | 112 | 9 | GSM538347_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-24ahi.Th, TCRd+ Vg2- CD24+, Thymus, avg-2 | 8.05e-05 | 422 | 112 | 10 | GSM476658_500 | |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_top-relative-expression-ranked_500 | MYH11 COL12A1 NT5E ADAM9 CD46 GLB1L2 MEF2C TIMP2 GUCY1B1 ARID5B | 9.22e-05 | 429 | 112 | 10 | gudmap_kidney_adult_Mesangium_Meis_500 |
| CoexpressionAtlas | gamma delta T cells, Tgd.Th, TCRd+ CD3e+, Thymus, avg-3 | 9.82e-05 | 349 | 112 | 9 | GSM476675_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_500 | 1.56e-04 | 152 | 112 | 6 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k2_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg1+vd6-.Th, TCRd+ Vg1.1+, Thymus, avg-3 | 1.62e-04 | 373 | 112 | 9 | GSM605781_500 | |
| CoexpressionAtlas | B cells, proB.FrBC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-1 | 1.72e-04 | 376 | 112 | 9 | GSM538418_500 | |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_top-relative-expression-ranked_1000 | MYH11 COL12A1 MYO1C NT5E ADAM9 CD46 GLB1L2 MEF2A MEF2C TIMP2 GUCY1B1 ARID5B HSPA1A HSPA1B | 2.00e-04 | 872 | 112 | 14 | gudmap_kidney_adult_Mesangium_Meis_1000 |
| CoexpressionAtlas | B cells, proB.FrA.BM, AA4.1+ CD117+ IL7R+ CD45R+ CD24- CD19- IgM-, Bone marrow, avg-1 | 2.11e-04 | 304 | 112 | 8 | GSM538354_500 | |
| CoexpressionAtlas | alpha beta T cells, NKT.44+NK1.1-.Th, aGC CD1d tet CD3 CD44, Thymus, avg-3 | 2.34e-04 | 392 | 112 | 9 | GSM538335_500 | |
| CoexpressionAtlas | B cells, preB.FrD.FL, AA4.1+ IgM- CD19+ CD43- CD24+, Fetal Liver, avg-3 | 2.48e-04 | 395 | 112 | 9 | GSM538340_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | MYH11 COL12A1 AHCYL2 LCN2 MEF2A JMJD1C MEF2C SULT1E1 ARID5B UTRN TOP1 TOP2A KNL1 | 3.02e-04 | 799 | 112 | 13 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | Stromal Cells, Ep.MEChi.Th, CD45-EpCAm+Ly51-MHCIIhi, Thymus, avg-1 | 3.32e-04 | 411 | 112 | 9 | GSM854302_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | ARHGAP42 KNTC1 LARS1 MELK SBNO1 PGAP1 CHEK2 AKAP11 TAF1 METTL25 MED23 ALPL CPEB1 | 3.44e-04 | 810 | 112 | 13 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.75e-04 | 251 | 112 | 7 | gudmap_developingLowerUrinaryTract_P1_bladder_J_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_k-means-cluster#1_top-relative-expression-ranked_500 | 4.23e-04 | 119 | 112 | 5 | gudmap_developingGonad_P2_testes_500_k1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.91e-08 | 191 | 116 | 8 | 7b0d42a877540dbb346a76a62403e0d5d3e07fa6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.91e-08 | 191 | 116 | 8 | cd854b9c426924fdc84bf7f411f6dea447143e79 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.62e-07 | 165 | 116 | 7 | 369d77a80d6401e85ea3121ab5a252f67d5f157e | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.47e-07 | 172 | 116 | 7 | 107417cfab7775bc1f80807115047abfb50b7a7e | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.05e-07 | 176 | 116 | 7 | 8b5c2fb7e5e551df658b1d5fc7f607a27bab00d5 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.21e-07 | 177 | 116 | 7 | a8625d14682183cf77cb51eaf11bc15a3528f586 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.21e-07 | 177 | 116 | 7 | 3645e2f4a48283f290f85c49c3e79e3f58ac9aa6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.67e-07 | 185 | 116 | 7 | 7092436b4db90289516ed130ade596e3021cffaf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.67e-07 | 185 | 116 | 7 | 51dfe6ac7df8b330343b37e3bee71e5c65267189 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.67e-07 | 185 | 116 | 7 | 35d39a1d04c871edcfb749653538dc5fd0054281 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.67e-07 | 185 | 116 | 7 | a8ca7819066d5297ef6966e7f3e2c9f8a7673fdc | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.67e-07 | 185 | 116 | 7 | a8c02cec3c414f3a0da9f2d6d28ce563b0030705 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.09e-07 | 187 | 116 | 7 | b8f88599e22b9b345c7ec3bbecd87a8b2a033f9f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.09e-07 | 187 | 116 | 7 | ec4b694487cc446999c7b27b119950a4f252c4b3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.09e-07 | 187 | 116 | 7 | 530e4e6d91b5c0d9aa4543caa2b734a1674c5788 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.32e-07 | 188 | 116 | 7 | 567b08514d9d84cbb40f9b7a679eec304f023428 | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.02e-07 | 191 | 116 | 7 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.53e-07 | 193 | 116 | 7 | bbdfda6665941cfa1965418bb91ef9ff43b1326f | |
| ToppCell | 18-Airway-Mesenchymal-Pericyte|Airway / Age, Tissue, Lineage and Cell class | 7.53e-07 | 193 | 116 | 7 | 9f4ba9c29ab8071d57e4187085ec3a47ab61e968 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.80e-07 | 194 | 116 | 7 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | 11.5-Distal-Mesenchymal-Pericyte|Distal / Age, Tissue, Lineage and Cell class | 7.80e-07 | 194 | 116 | 7 | 08701590496cf85ff790e54a81493c61177e76ff | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.80e-07 | 194 | 116 | 7 | 3b9ada901dfe7a5cc4861a883d3268c53b11e5b6 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.07e-07 | 195 | 116 | 7 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.35e-07 | 196 | 116 | 7 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-vRG-11|World / Primary Cells by Cluster | 8.94e-07 | 198 | 116 | 7 | 672c6faeed54e1397e12c0aac1a5cbd19c684f06 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.24e-07 | 199 | 116 | 7 | 9e32644b93fb1c4946dbe388fd5c357304d14e36 | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.42e-06 | 156 | 116 | 6 | 8349604bd801e20d33770f7d8243598c3756302b | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.56e-06 | 164 | 116 | 6 | e5258efd6765acfc394708f697ec76acaef09079 | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-cDC2-cDC2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.24e-06 | 168 | 116 | 6 | 4c402a1613fcf0a6e4d9b9d5551812940e91ff32 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.24e-06 | 168 | 116 | 6 | a1755afa2cc50960ba60e07d84d61be429cdea72 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.60e-06 | 170 | 116 | 6 | d9ed257d0938442d0bb280e4c4b0c9b657511b46 | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.60e-06 | 170 | 116 | 6 | 9e94fa0d05abed3438b28296a293767096d517d6 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.20e-06 | 173 | 116 | 6 | fc2602b2ce051cd4c33957d7e3d041ff8a529883 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.20e-06 | 173 | 116 | 6 | 901b8e6909c1f3849906fad9cee17b8f0bab050d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.40e-06 | 174 | 116 | 6 | 7b318796728001c17b4043d2b033330c7be40c78 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.40e-06 | 174 | 116 | 6 | 41eb0a214a8b4015a26311f77061c8147144f0e7 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.40e-06 | 174 | 116 | 6 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.62e-06 | 175 | 116 | 6 | 15c69dd5635c9251c535f1e22467712e9667ae92 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.62e-06 | 175 | 116 | 6 | 9de288c338cee67be0e9b836c87799bbc1db1c38 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.06e-06 | 177 | 116 | 6 | 4943d040eee0f9dceaddc7498171281d170e271f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.06e-06 | 177 | 116 | 6 | 3f2272b577c862dba8ccfb41184054bbd0ace6f5 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.29e-06 | 178 | 116 | 6 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| ToppCell | COVID-19-kidney-Stressed_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.53e-06 | 179 | 116 | 6 | 754f69bac7a1d5137f5141f6193285ccbfe361cb | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.53e-06 | 179 | 116 | 6 | 54621d2b3a66e62aa76b7e444118878ed97c1e02 | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.02e-06 | 181 | 116 | 6 | 57f0cc749ae8b6a3d77e2af31f9a6e4739c57049 | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.02e-06 | 181 | 116 | 6 | d01b35cc2fc57991a35be6a06cb7351fbabd9a11 | |
| ToppCell | LA-07._Pericyte|World / Chamber and Cluster_Paper | 8.54e-06 | 183 | 116 | 6 | e3835db4795362b0442d5893baf2a78efcc20428 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.81e-06 | 184 | 116 | 6 | d1e0e3b0eed2db8a5b7e3d6f81294667e4ba64e5 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.37e-06 | 186 | 116 | 6 | 86d145f965c311189e7996390eef491642417c5c | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|lung / Disease (COVID-19 only), tissue and cell type | 9.37e-06 | 186 | 116 | 6 | 66676d9395172de5707e204826a1c9f73b448cca | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.37e-06 | 186 | 116 | 6 | db4d9ac89cc1e55062ba888b3410b773340595dd | |
| ToppCell | Dendritic_Cells-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 9.37e-06 | 186 | 116 | 6 | 1d52912bd17e232cf39b2423a4d93585c164ba34 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.37e-06 | 186 | 116 | 6 | 4ae3c0fe8640a8d029875cf3f0f5ffbba38e85f8 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.66e-06 | 187 | 116 | 6 | 48bfdb3504c3fefe5db3abac4b790c369680ab4e | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.66e-06 | 187 | 116 | 6 | a9316e2818217ec5feae9cf8816f7249803caee6 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.66e-06 | 187 | 116 | 6 | 6820bfbe552ea5e62cfe699687b051a17d9fda61 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.66e-06 | 187 | 116 | 6 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.66e-06 | 187 | 116 | 6 | 958402fcc78f4c7a7d13d659d776f3817137975f | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.66e-06 | 187 | 116 | 6 | 8ee3bf885897efd634c3a0567637142a9f55e693 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.96e-06 | 188 | 116 | 6 | ccddc08121caff958a2b6f9e278a018858af6b4d | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.96e-06 | 188 | 116 | 6 | ee151792c7ac9afe820f1a281c6dab383799f358 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-05 | 190 | 116 | 6 | 5681c211baeed4af82a2bbc13420f6a7b487581c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.06e-05 | 190 | 116 | 6 | d6b3a92119b210974a32af3fe9875d60eb02761e | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.06e-05 | 190 | 116 | 6 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.06e-05 | 190 | 116 | 6 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 1.09e-05 | 191 | 116 | 6 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.12e-05 | 192 | 116 | 6 | 5000440dc1ed17e7474d340921bdff945646f27e | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-Pericytes|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.16e-05 | 193 | 116 | 6 | 47d189bac0ef4df2f5c6dd987e46aca85bd7e2af | |
| ToppCell | E15.5-Mesenchymal-myocytic_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.16e-05 | 193 | 116 | 6 | 3316d6a39abb6a518d45b846254325fc7a8b2035 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.16e-05 | 193 | 116 | 6 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-proliferating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-05 | 193 | 116 | 6 | f20b90e3f3f5c9a1ae51c5ebe6d3adb954a142f2 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.16e-05 | 193 | 116 | 6 | 516ea2c12bdc7a5dc676159d627e36f6abe13ef0 | |
| ToppCell | IPF-Stromal-Pericyte|Stromal / Disease state, Lineage and Cell class | 1.19e-05 | 194 | 116 | 6 | 3892b188f424ffb80f3c75a1b6709a21c1e1601d | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.19e-05 | 194 | 116 | 6 | 7a7406c3b021aeafde423d20290c681c3e8ea0a6 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.19e-05 | 194 | 116 | 6 | 590a9d4f054e6a3685daf752c9354650fcc7d18a | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.19e-05 | 194 | 116 | 6 | 3a49c7c86036e09a8cd0114988380d04ad1a26fb | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 1.23e-05 | 195 | 116 | 6 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.23e-05 | 195 | 116 | 6 | 481989d2e5bd2582da3d86b0155c4d6615317067 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.23e-05 | 195 | 116 | 6 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.23e-05 | 195 | 116 | 6 | 6108a27523d1b93a7fbe35cb95704a5ad9071e3c | |
| ToppCell | normal_Lung-T/NK_cells-Cytotoxic_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 1.23e-05 | 195 | 116 | 6 | 3af8ea15e2ac8efdeb4d4f69357b83b8dbcfab8d | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.23e-05 | 195 | 116 | 6 | 751cb00b0f3005be6b645adadfbb9dd2215b6e08 | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 1.23e-05 | 195 | 116 | 6 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.23e-05 | 195 | 116 | 6 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 1.23e-05 | 195 | 116 | 6 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.23e-05 | 195 | 116 | 6 | 5790b47b0e028e49b99bda8d6d9e80ac79208cdf | |
| ToppCell | droplet-Bladder-nan-24m-Endothelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 196 | 116 | 6 | 9a90dd26e7a43e3fd55e7c5d8354cfa4cdd5a6cc | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.26e-05 | 196 | 116 | 6 | 624f700daea48d9bad4cc554f4776bd809ae1e54 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.26e-05 | 196 | 116 | 6 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.26e-05 | 196 | 116 | 6 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 1.26e-05 | 196 | 116 | 6 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.26e-05 | 196 | 116 | 6 | 01cea0bb0b938d0986fd2ddae06597b8af1768ee | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 1.26e-05 | 196 | 116 | 6 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | droplet-Bladder-nan-24m-Endothelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 196 | 116 | 6 | 04dfef1bd4ebb0e9469ae80024dc177e469a2560 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.30e-05 | 197 | 116 | 6 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast-(8)_Pericytes|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.30e-05 | 197 | 116 | 6 | 608328608cef82adc867a449216839622253d486 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Pericytes|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.34e-05 | 198 | 116 | 6 | 5e274c5597d8720290d452465f0bd40637cb3f27 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-05 | 198 | 116 | 6 | d484ac79d6cd29f1d9c192d126c2099f737d5320 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating-cycling_dorsal_progenitors|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.34e-05 | 198 | 116 | 6 | 5f0964c3aa7e1dc52cbb46e754078920b65bcb88 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.34e-05 | 198 | 116 | 6 | 629d674a9c9108c1acb3f7af57bbdbf34bb0528e | |
| Drug | EHNA | 5.27e-06 | 87 | 115 | 6 | CID000003206 | |
| Drug | EUK-8 | 7.20e-06 | 25 | 115 | 4 | CID000171249 | |
| Drug | 11-keto-boswellic acid | 1.47e-05 | 10 | 115 | 3 | ctd:C447943 | |
| Drug | AC1LCV0V | 1.99e-05 | 32 | 115 | 4 | CID000656468 | |
| Drug | batracylin | 2.53e-05 | 2 | 115 | 2 | ctd:C057924 | |
| Drug | NSC636979 | 2.53e-05 | 2 | 115 | 2 | CID000367344 | |
| Drug | boswellic acid | 2.53e-05 | 2 | 115 | 2 | ctd:C054625 | |
| Drug | MDL-28842 | 2.67e-05 | 12 | 115 | 3 | CID006441200 | |
| Drug | Glucosamine | 2.92e-05 | 311 | 115 | 9 | ctd:D005944 | |
| Drug | arabinosyladenine | AHCYL1 NT5E IARS1 LARS1 AHCYL2 ADA2 NLRP14 ADSS2 GUCY1B1 CYCS MED23 ATP2A1 ATP2A2 ALPL | 3.07e-05 | 762 | 115 | 14 | CID000000191 |
| Disease | Brody myopathy (implicated_via_orthology) | 4.35e-05 | 3 | 113 | 2 | DOID:0050692 (implicated_via_orthology) | |
| Disease | Marfan syndrome (is_marker_for) | 8.68e-05 | 4 | 113 | 2 | DOID:14323 (is_marker_for) | |
| Disease | graft-versus-host disease (biomarker_via_orthology) | 1.44e-04 | 5 | 113 | 2 | DOID:0081267 (biomarker_via_orthology) | |
| Disease | attention deficit hyperactivity disorder (implicated_via_orthology) | 1.67e-04 | 28 | 113 | 3 | DOID:1094 (implicated_via_orthology) | |
| Disease | alkaline phosphatase measurement, liver enzyme measurement | 2.16e-04 | 6 | 113 | 2 | EFO_0004533, EFO_0004582 | |
| Disease | urinary tract infection (is_implicated_in) | 2.16e-04 | 6 | 113 | 2 | DOID:0080784 (is_implicated_in) | |
| Disease | Major depression, single episode | 5.14e-04 | 9 | 113 | 2 | C0024517 | |
| Disease | Tumoral calcinosis | 5.63e-04 | 42 | 113 | 3 | C0263628 | |
| Disease | Calcinosis | 5.63e-04 | 42 | 113 | 3 | C0006663 | |
| Disease | Microcalcification | 5.63e-04 | 42 | 113 | 3 | C0521174 | |
| Disease | cervix uteri carcinoma in situ (is_marker_for) | 5.63e-04 | 42 | 113 | 3 | DOID:8991 (is_marker_for) | |
| Disease | status epilepticus (biomarker_via_orthology) | 6.03e-04 | 100 | 113 | 4 | DOID:1824 (biomarker_via_orthology) | |
| Disease | vitamin B6 measurement | 6.41e-04 | 10 | 113 | 2 | EFO_0004621 | |
| Disease | Neuroblastoma | 7.84e-04 | 47 | 113 | 3 | C0027819 | |
| Disease | waist-hip ratio | KNTC1 MYH11 DNAH10 SYTL2 MEF2A JMJD1C PBRM1 TIMP2 DNAH17 ARID5B ATP2A1 TOP1 KNL1 | 8.43e-04 | 1226 | 113 | 13 | EFO_0004343 |
| Disease | disks large homolog 3 measurement | 9.36e-04 | 12 | 113 | 2 | EFO_0802472 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 9.44e-04 | 195 | 113 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | thoracic aortic aneurysm (is_marker_for) | 1.28e-03 | 14 | 113 | 2 | DOID:14004 (is_marker_for) | |
| Disease | immunoglobulin lambda-like polypeptide 1 measurement | 1.68e-03 | 16 | 113 | 2 | EFO_0801688 | |
| Disease | major depressive disorder (is_implicated_in) | 1.90e-03 | 17 | 113 | 2 | DOID:1470 (is_implicated_in) | |
| Disease | glucose homeostasis measurement, acute insulin response measurement | 2.14e-03 | 18 | 113 | 2 | EFO_0006831, EFO_0006896 | |
| Disease | noggin measurement | 2.14e-03 | 18 | 113 | 2 | EFO_0021995 | |
| Disease | venous thromboembolism, fibrinogen measurement | 2.19e-03 | 67 | 113 | 3 | EFO_0004286, EFO_0004623 | |
| Disease | intrahepatic cholangiocarcinoma (is_marker_for) | 2.38e-03 | 19 | 113 | 2 | DOID:4928 (is_marker_for) | |
| Disease | Nonorganic psychosis | 2.38e-03 | 69 | 113 | 3 | C0349204 | |
| Disease | chemokine (C-C motif) ligand 27 measurement | 2.48e-03 | 70 | 113 | 3 | EFO_0008082 | |
| Disease | Prostatic Neoplasms | 2.59e-03 | 616 | 113 | 8 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 2.59e-03 | 616 | 113 | 8 | C0376358 | |
| Disease | Liver diseases | 2.69e-03 | 72 | 113 | 3 | C0023895 | |
| Disease | Liver Dysfunction | 2.69e-03 | 72 | 113 | 3 | C0086565 | |
| Disease | Malignant neoplasm of breast | DSC3 MCF2L2 NLRP14 PBRM1 SBNO1 CHD5 CHEK2 HSPA1B CDH5 TOP1 TOP2A | 2.79e-03 | 1074 | 113 | 11 | C0006142 |
| Disease | Liver Cirrhosis, Experimental | 2.97e-03 | 774 | 113 | 9 | C0023893 | |
| Disease | intellectual disability (implicated_via_orthology) | 3.02e-03 | 75 | 113 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | interleukin 10 measurement | 3.38e-03 | 78 | 113 | 3 | EFO_0004750 | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 3.63e-03 | 80 | 113 | 3 | DOID:6432 (biomarker_via_orthology) | |
| Disease | cancer (implicated_via_orthology) | 3.77e-03 | 268 | 113 | 5 | DOID:162 (implicated_via_orthology) | |
| Disease | Disease Exacerbation | 3.78e-03 | 165 | 113 | 4 | C0235874 | |
| Disease | Carcinoma, Pancreatic Ductal | 3.80e-03 | 24 | 113 | 2 | C0887833 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KMAVKEEKYDPGYEA | 326 | Q13569 | |
| YFSYDVKMKEKGDIP | 66 | A0A5B6 | |
| YLLGRPIDKYVFEKM | 86 | Q9NXE8 | |
| AKMEERFYRYGIKPE | 576 | Q8TDI0 | |
| DQMEPYLIELSKKYG | 181 | Q7L8W6 | |
| IMVTKPVQEYKKEYT | 751 | Q9UKA4 | |
| VPKLSRNYLKEGYME | 246 | O75689 | |
| RNYLKEGYMEKTGPK | 251 | O75689 | |
| PAYQAMELEYVLKKV | 156 | Q96CM8 | |
| MVKETQYYDILGVKP | 1 | Q8WW22 | |
| RLDMYGEKYKPFKGV | 391 | Q9Y2T2 | |
| VYPKALRDEYIMSKT | 211 | O96017 | |
| EGIIKPMKPLDYEYI | 316 | P33151 | |
| IEALKEYEPEMGKVY | 116 | O14983 | |
| NPYIRMTKEKYGKEC | 31 | Q9NW64 | |
| YGLEINKLPVTKMKY | 41 | P39900 | |
| ALYKKIMRGKYDVPK | 216 | Q14680 | |
| KLRYYGKPDKKMIEP | 246 | Q6NSI4 | |
| DLLMKYIYKGFEKPT | 106 | Q9BPX5 | |
| RLDMYGEKYKPFKGI | 391 | P53677 | |
| YKYIFDAMVQGKVTP | 221 | Q9H790 | |
| TPMIGDKVYVHYKGK | 46 | Q13451 | |
| YYLTIKKPMDMEKIR | 696 | Q86U86 | |
| MYRVYGKKNIKLEPV | 621 | Q13045 | |
| VIKKYKDYFPMIFGK | 486 | Q8TD91 | |
| FEAMELIGKPKPYYE | 41 | P15529 | |
| YDREMKNYVPPKGDK | 71 | P26583 | |
| YRPADKDYGLMKIDE | 56 | Q96PQ5 | |
| DESKLPEKIIMNYYE | 521 | Q8N6Q8 | |
| PEKIIMNYYEKYKPR | 526 | Q8N6Q8 | |
| IPDEEKMKEEKYDYI | 321 | Q15652 | |
| KYYRNEFKTKVPIIM | 151 | Q86YR7 | |
| KIYRMIKLGLGVDEY | 286 | Q58FG0 | |
| KMKEIAEAYLGYPVT | 126 | P0DMV9 | |
| LTIKETGRYPAYKEM | 286 | Q9H5P4 | |
| MKYHVSEKPYGIVEK | 86 | O95139 | |
| KLAPFLKMYGEYVKG | 291 | Q96M96 | |
| MKLFDLLYPEKEYIP | 396 | Q9ULK4 | |
| LPKDQMKVYVDDIYV | 1451 | Q8NG31 | |
| KLDPYDYEMIEVVLK | 1521 | P50748 | |
| DMDKVLLKYTEYNEP | 61 | Q06413 | |
| NPFVYKVETVGDKYM | 466 | Q02153 | |
| LVVPMNKEKYEGYLR | 531 | Q96M69 | |
| KDVKSEVAMLYPELY | 896 | O75110 | |
| DMDKVLLKYTEYNEP | 61 | Q02078 | |
| VGYIEPSKFQKIIYM | 361 | Q6NUT2 | |
| MNGPADGEVDYKKKY | 1 | Q8NBZ0 | |
| VLYLIKPLDYEKMTK | 2721 | Q6V1P9 | |
| KDPQKMYATIYELKE | 66 | P80188 | |
| GGRKYMYPKNKTDVE | 221 | P05186 | |
| GLYKERMTELYDYPK | 61 | P48147 | |
| KGDRVMPEEIARYYK | 166 | Q9Y236 | |
| EKIPKYVEFMKDNYP | 81 | Q9BTY2 | |
| IEALKEYEPEMGKVY | 116 | P16615 | |
| GEDTLMEYLENPKKY | 61 | P99999 | |
| MEYLENPKKYIPGTK | 66 | P99999 | |
| YVVICKPKMGYTDIL | 581 | Q14574 | |
| YDITVLPIYKMGEGK | 1061 | Q99715 | |
| PLKVGLGMYSKEDEY | 1626 | Q9UFH2 | |
| YHYPELKEEKGIVLM | 241 | Q5TC12 | |
| VYVIDSGKMKEKRYD | 926 | Q6P158 | |
| GDEYRIKPVEEVKYM | 31 | Q9H246 | |
| DYKEALMIPAKDGVK | 336 | Q9NZK5 | |
| IIYRMDDVYKEPLKC | 161 | Q13443 | |
| VAPYKIERGKMEYVF | 121 | Q92636 | |
| YMDYSVGILIKKPEE | 536 | Q9ULK0 | |
| NMPKGYVYLVFELEK | 356 | Q9BZB8 | |
| SQSKIYLYKDGEMIP | 241 | Q86VF2 | |
| YMPYVKKALEDRGIV | 211 | Q8IW92 | |
| KMKEIAEAYLGYPVT | 126 | P0DMV8 | |
| IYEMVAGRTPFKDYK | 381 | Q8WTQ7 | |
| LVDYFKDSGMKRIPY | 351 | O94887 | |
| MIYELYEGLKVAKEE | 1266 | Q8IVF4 | |
| LVLGYKVMYKEKDSD | 1231 | Q58EX2 | |
| TYAEYMPIKLKIGLR | 241 | A3KN83 | |
| VGYIEPSKFQKIIYM | 171 | Q6ZN68 | |
| DMDKVLLKYTEYNEP | 61 | Q14814 | |
| SPEVLDYMLQKEEKY | 1391 | Q5THK1 | |
| DPYVKAYLLPDKGKM | 666 | Q9HCH5 | |
| KYRYLFKEVAGPTEM | 2971 | P46939 | |
| GRYKQDVYLLPKKMD | 556 | Q96HN2 | |
| DVYLLPKKMDEYVAS | 561 | Q96HN2 | |
| KKIGTYVEVDMYGLP | 716 | Q15147 | |
| KGMILYLQKEEYKPG | 791 | A5PKW4 | |
| YTLPAIISKKEEMYL | 376 | A6NI28 | |
| RYKQDVYLLPKKMDE | 476 | O43865 | |
| VYLLPKKMDEYVASL | 481 | O43865 | |
| KIYLKGFYEGIMLVD | 466 | Q9P2J5 | |
| KVVKDYYKIITRPMD | 1431 | Q8IZX4 | |
| AKVVKDYYKIITRPM | 1411 | P21675 | |
| KKIYYRPALMTAIDG | 726 | Q86V20 | |
| MKPIDYYTETKILQE | 166 | Q15738 | |
| YATMLDKEAKPYKVD | 626 | Q75T13 | |
| LYDKGLVYRGVKVMP | 166 | P41252 | |
| KIKPMVRDGVYFLYE | 226 | P30520 | |
| MAVRKKDGGPNVKYY | 1 | Q8TAQ2 | |
| YISKMKVIYPAVEGR | 531 | P21589 | |
| EDLPSKLEGFKEKYM | 41 | P55008 | |
| VALYKYMKERKTPIE | 326 | Q14865 | |
| PGKYYKEATLTMDQV | 41 | A0PJX0 | |
| LPIYSEKIVDMYKGK | 131 | P35749 | |
| KDEIEKIKAYPYMEG | 66 | Q9BYD6 | |
| QAGIPKEEEYKLMYG | 26 | Q9Y5R8 | |
| MEVGKEKCLPVYYEQ | 226 | O60704 | |
| MDDLKYGVYPLKEAS | 1 | Q8TF32 | |
| IIKMYKKGENPVSYA | 466 | Q9P2K2 | |
| IVYMIYKEGDVEKCK | 56 | P49888 | |
| IIYLKKPMIISYKEV | 366 | Q5T4T6 | |
| IKMFKGPEKDIEFIY | 76 | P16035 | |
| PLATYMRIYKKGDIV | 26 | P46778 | |
| DAIKKMIGAFKYYPI | 651 | Q9BY07 | |
| KIMIYLIDKVLPESY | 361 | Q9Y2I9 | |
| VPMCKEYEVKVIGYN | 56 | Q8TE23 | |
| KYMETVKLLDYTEKP | 301 | Q99986 | |
| YKGPMSAVYIEKFVR | 196 | Q6PKC3 | |
| KLPVKGFRSYVDMYL | 261 | P11388 | |
| YGIYEMIPKEKLVTD | 331 | O43895 | |
| YYDGKVMKLSPKAEE | 241 | P11387 | |
| EDLANLMKKYYPGEK | 56 | Q86W24 | |
| LGYKPEEYKMGRTKI | 701 | O00159 | |
| EEYEKNKGKPMLEFV | 341 | O76041 | |
| RMGYEELKRKGYDLP | 2516 | P20929 |